DAVIES PHARMACEUTICALS Trademark

Trademark Overview

On Wednesday, October 12, 2022, a trademark application was filed for DAVIES PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the DAVIES PHARMACEUTICALS trademark a serial number of 97628980. The federal status of this trademark filing is REVIVED - AWAITING FURTHER ACTION as of Monday, February 26, 2024. This trademark is owned by Davies Pharmaceuticals, LLC. The DAVIES PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of psychotic and neurological diseases
davies pharmaceuticals

General Information

Serial Number97628980
Word MarkDAVIES PHARMACEUTICALS
Filing DateWednesday, October 12, 2022
Status616 - REVIVED - AWAITING FURTHER ACTION
Status DateMonday, February 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of psychotic and neurological diseases
NOT AVAILABLE"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDavies Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCrown Point, IN 46307

Trademark Events

Event DateEvent Description
Saturday, October 15, 2022NEW APPLICATION ENTERED
Monday, October 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 24, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Wednesday, May 24, 2023WITHDRAWAL OF ATTORNEY GRANTED
Thursday, July 27, 2023ASSIGNED TO EXAMINER
Thursday, November 9, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, August 9, 2023NON-FINAL ACTION WRITTEN
Wednesday, August 9, 2023NON-FINAL ACTION E-MAILED
Wednesday, August 9, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 22, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, February 22, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, November 9, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, February 26, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 26, 2024NOTICE OF REVIVAL - E-MAILED
Monday, February 26, 2024NOTICE OF REVIVAL - E-MAILED
Monday, February 26, 2024PETITION TO REVIVE-GRANTED
Monday, February 26, 2024TEAS PETITION TO REVIVE RECEIVED
Monday, February 26, 2024TEAS PETITION TO REVIVE RECEIVED
Monday, August 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 12, 2024ASSIGNED TO LIE

Related Keywords

pharmaceuticals davies neurological diseases psychotic treatment preparations pharmaceutical